Indivior Pharmaceuticals (INDV) Shares Outstanding (2021 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Shares Outstanding (Entity) of $24.8 million for Q1 2026, little changed year-over-year from $24.8 million in Q1 2025, and down 0.8% quarter-over-quarter from $25.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Shares Outstanding (2021 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Shares Outstanding (Entity) history runs 6 years deep, the most recent figure standing at $24.8 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) changed 0.0% year-over-year to $24.8 million; the TTM figure through Mar 2026 stood at $24.8 million (changed 0.0% YoY), while the FY2025 annual figure was $25.0 million, down 5.3% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $24.8 million, down from $25.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $27.8 million in Q4 2022, with the low at $24.8 million in Q1 2025.
- The 5-year median for Shares Outstanding (Entity) is $26.4 million (2024), against an average of $26.1 million.
- The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) fell 8.82% in 2025, then changed 0.0% in 2026.
- Indivior Pharmaceuticals' Shares Outstanding (Entity) stood at $27.8 million in 2022, then decreased by 1.44% to $27.4 million in 2023, then slipped by 3.65% to $26.4 million in 2024, then decreased by 5.3% to $25.0 million in 2025, then slipped by 0.8% to $24.8 million in 2026.
- Business Quant data shows INDV's Shares Outstanding (Entity) at $24.8 million in Q1 2026, $25.0 million in Q4 2025, and $25.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | Indivior Pharmaceuticals | 4.60 Bn | 4.38 Bn | 294.00 Mn | 119.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 119.00 Mn |
| Mar 31, 2026 | 124.00 Mn |
| Dec 31, 2025 | 125.00 Mn |
| Sep 30, 2025 | 125.00 Mn |
| Jun 30, 2025 | 125.00 Mn |
| Mar 31, 2025 | 124.00 Mn |
| Dec 31, 2024 | 132.00 Mn |
| Sep 30, 2024 | 132.00 Mn |
| Jun 30, 2024 | 135.00 Mn |
| Mar 31, 2024 | 136.00 Mn |
| Dec 31, 2023 | 137.00 Mn |
| Dec 31, 2022 | 139.00 Mn |
| Dec 31, 2021 | 145.66 Mn |